Clinical Trial Update: Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of a single intra-anal dose of NRL001 in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• NRL001

Snippet

Sponsor: Norgine | Conditions: Fecal Incontinence | Phase 1 | Status: COMPLETED